Showing posts with the label MerckShow all
October 29, 2021
An update on the Merck COVID-19 pill for the US
Because the US enters its second Halloween in a pandemic, COVID-19 is surging once more in different elements of the w…
Read more
October 28, 2021
India's Optimus Pharma seeks approval to produce generic Merck COVID-19 pill
A pc picture created by Nexu Science Communication along with Trinity Faculty in Dublin, exhibits a mannequin structur…
Read more
October 27, 2021
Merck signs pact to allow more companies to manufacture COVID-19 pill
Merck has signed a licensing settlement with the United Nations-backed Medicines Patent Pool (MPP) that can permit ext…
Read more
October 27, 2021
Merck signs pact to broaden generic manufacturing of COVID-19 pill
The Merck emblem is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Br…
Read more
October 11, 2021
Merck aims to double supply of Covid-19 antiviral pill on rising demand
Merck plans to double manufacturing capability for its antiviral capsule to deal with Covid-19 subsequent yr as govern…
Read more
October 11, 2021
Merck seeks first U.S. FDA authorization for COVID-19 tablet
The Merck emblem is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Br…
Read more
October 07, 2021
Merck and Singapore sign deal on COVID-19 antiviral drug
Pharmaceutical firm Merck introduced on Wednesday a provide and buy settlement with Singapore that may guarantee it en…
Read more